Prosecution Insights
Last updated: May 04, 2026
Application No. 18/223,903

TEMPERATURE CONTROL METHODS AND DEVICES

Non-Final OA §102§103§112
Filed
Jul 19, 2023
Priority
Jan 19, 2021 — provisional 63/139,000 +1 more
Examiner
GERIDO, DWAN A
Art Unit
1797
Tech Center
1700 — Chemical & Materials Engineering
Assignee
10X Genomics, Inc.
OA Round
1 (Non-Final)
58%
Grant Probability
Moderate
1-2
OA Rounds
6m
Est. Remaining
89%
With Interview

Examiner Intelligence

Grants 58% of resolved cases
58%
Career Allowance Rate
412 granted / 714 resolved
-7.3% vs TC avg
Strong +31% interview lift
Without
With
+31.1%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
48 currently pending
Career history
762
Total Applications
across all art units

Statute-Specific Performance

§101
4.4%
-35.6% vs TC avg
§103
47.3%
+7.3% vs TC avg
§102
20.8%
-19.2% vs TC avg
§112
23.1%
-16.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 714 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 8 and 19-22 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. For claim 8, the phrase “prior to insertion into the housing” is unclear as the Examiner is unable to determine if the tray is heated prior to inserting the tray into the housing, or if the claim intends to recite preheating or precooling the tray prior to inserting the microfluidic device into the housing. As such, it is unclear what is being inserted into the housing with respect to the tray and the microfluidic device. For claim 19, the claim is indefinite because it recites a process limitation in a claim directed to a device (MPEP 2173.05(p)). The limitations of “wherein the thermal energy source heats or cools the microfluidic device by overshooting the first temperature and then reducing the overshoot until the microfluidic device reaches the first temperature” is a process limitation. As set forth in the MPEP, process limitations in a claim directed to a device are indefinite as it is unclear whether infringement occurs when on makes the device, or whether infringement occurs when the device is utilized in the manner recited in the claim. Claim 20 recites the limitation "the acceleration" in line 1. There is insufficient antecedent basis for this limitation in the claim. Additionally, the Examiner notes that claim 20 recites a process limitation in a claim directed to a device (MPEP 2173.05(p)). As set forth in the MPEP, process limitations in a claim directed to a device are indefinite as it is unclear whether infringement occurs when on makes the device, or whether infringement occurs when the device is utilized in the manner recited in the claim. As such, one cannot determine if infringement of claim 20 occurs when one makes the claimed device, or if infringement occurs when the claimed device is utilized in the manner recited in the claim. For claim 21, the claim is indefinite because it recites a process limitation in a claim directed to a device (MPEP 2173.05(p)). The limitation of “the thermal energy source preheats or precools the tray prior to insertion into the housing” is a process limitation. As such, one cannot determine if infringement occurs when the claimed device is made, or if infringement occurs when one utilizes the device in the manner recited in the claim. Additionally, it is unclear if the claimed tray is a structural element of the device, or if the tray is a separate element, that is placed into the device prior to use. For claim 22, the claim is indefinite because it recites a process limitation in a claim directed to a device (MPEP 2173.05(p)). The limitation of “the microfluidic device is placed in a thermally conductive holder” is a process limitation. As such, one cannot determine if infringement occurs when the claimed device is made, or if infringement occurs when one utilizes the device in the manner recited in the claim. Additionally, it is unclear if the claimed thermally conductive holder is a structural element of the device, or if the holder is a separate element that is placed in the device prior to use. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-3, 6, 7, 10, 12-18, and 19-22 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Kimball et al., (US 2013/0078610). For claim 1, Kimball et al., teach a method for thermal cycling of microfluidic samples comprising providing a thermal cycler for performing an assay at a first temperature (paragraph 0008) wherein the thermal cycler comprises a housing and a thermal chuck (tray, paragraph 0035) for holding the microfluidic device (paragraph 0035) wherein the thermal chuck comprises a thermal energy source (paragraph 0035). Kimball et al., teach the thermal cycler having an ambient temperature sensor (paragraph 0052) and a temperature sensor that measures the temperature of the microfluidic device (paragraph 0052). Kimball et al., also teach placing the microfluidic device in the thermal chuck (paragraph 0035), determining a difference between ambient temperature and the first temperature (paragraphs 0051, 0052), and heating the microfluidic device by overshooting the first temperature, and cooling until the microfluidic device meets the first temperature (paragraph 0064, figure 8A). For claim 2, Kimball et al., teach a thermoelectric cooler (paragraph 0034) comprising a heatsink (paragraph 0029). For claim 3, Kimball et al., teach thermistors as the temperature sensors (paragraphs 0040, 0049, 0052). For claims 6 and 7, Kimball et al., heating the microfluidic device by overshooting the first temperature, and cooling until the microfluidic device meets the first temperature (paragraph 0064, figure 8A). With respect to claim 7, the prior art overshoot only occurs when the tray and microfluidic device are placed into the thermocycler, thus the overshoot is necessarily initiated when the tray is inserted into the thermocycler (paragraph 0064). For claim 10, Kimball et al., teach ambient temperature at 25°C (paragraph 0052). For claim 12, Kimball et al., teach the microfluidic device reaching a temperature within 1°C of the first temperature in less than 60 seconds (paragraph 0056). For claim 13, Kimball et al., teach the microfluidic device reaching a temperature within 0.5°C of the first temperature in less than 60 seconds (paragraph 0056). For claim 14, Kimball et al., teach a thermal cycler comprising a housing and a thermal chuck (tray, paragraph 0035) for holding the microfluidic device (paragraph 0035), and a thermal energy source (paragraph 0035). Kimball et al., also teach heating the microfluidic device by overshooting the first temperature, and cooling until the microfluidic device meets the first temperature (paragraph 0064, figure 8A). For claim 15, Kimball et al., teach a thermoelectric cooler (paragraph 0034) comprising a heatsink (paragraph 0029). For claim 16, Kimball et al., teach thermistors as the temperature sensors (paragraphs 0040, 0049, 0052). For claims 17 and 18, Kimball et al., teach an infrared sensor (paragraph 0042). For claims 19-22, the Examiner notes that the claims are being read in light of the rejections under 35 U.S.C 112(b) in which the claims are directed to a device, but recite process limitations. Because reference to Kimball et al., teach a device identical to that of the instant claims, the Examiner contends that the prior art device would be fully capable of performing the process limitations recited in claims 19-22. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 11 is/are rejected under 35 U.S.C. 103 as being unpatentable over Kimball et al., (US 2013/0078610). Regarding claim 11, Kimball et al., teach an ambient temperature of 25°C, but do not teach performing an assay at a first temperature ranging from 20°C to 25°C. The Examiner is reading this limitation as optimization by routine experimentation which would have been obvious to one of ordinary skill in the art (MPEP 2144.05 II A). The MPEP states that differences in concentration or temperature does not support patentability of subject matter encompassed by the prior art absent evidence indicating the concentration or temperature to be critical (MPEP 2144.05 II A). Reference to Kimball et al., is directed to nucleic acid amplification which occurs at temperatures higher than 20 to 25°C. However, one of ordinary skill in the art would have recognized that thermocyclers can be utilized for assays that require lower temperatures. As such, one of ordinary skill in the art would have found it obvious to set the first temperature at 20 to 25°C based on the assay being performed. Therefore, it would have been obvious to one of ordinary skill in the art at the time the invention was made to modify Kimball et al., wherein the first temperature ranges from 20°C to 25°C as optimization requires only routine skill in the art. Claim(s) 9 is/are rejected under 35 U.S.C. 103 as being unpatentable over Kimball et al., (US 2013/0078610) in view of Mikkelsen et al., (US 2022/0275434). Regarding claim 9, Kimball et al., do not teach placing the microfluidic device in a thermally conductive holder. Mikkelsen et al., teach a method for amplifying nucleic acids wherein a microfluidic device is placed into a thermally conductive holder (paragraph 0083). Mikkelsen et al., teach that it is advantageous to utilize a thermally conductive holder as a means of cooling the microfluidic device to prevent temperature dependent reactions from occurring while the microfluidic device is placed into the system (paragraph 0083). Therefore, it would have been obvious to one of ordinary skill in the art at the time the invention was made to modify Kimball et al., wherein the microfluidic device is placed into a thermally conductive holder in order to prevent temperature dependent reactions from occurring in the microfluidic device as taught by Mikkelsen et al. Allowable Subject Matter Claim 8 would be allowable if rewritten to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action and to include all of the limitations of the base claim and any intervening claims. The following is a statement of reasons for the indication of allowable subject matter: the prior art of record does not teach or suggest a method for controlling temperature of a microfluidic device comprising providing an instrument for performing an assay at a first temperature wherein the instrument comprises a housing and a tray for inserting a microfluidic device into the housing and removing a microfluidic device from the housing wherein the tray comprises a thermal energy source, and is preheated or precooled prior to insertion into the housing. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to DWAN A GERIDO whose telephone number is (571)270-3714. The examiner can normally be reached Mon-Fri 10-6. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Lyle Alexander can be reached at (571) 272-1254. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /DWAN A GERIDO/Examiner, Art Unit 1797 /LYLE ALEXANDER/Supervisory Patent Examiner, Art Unit 1797
Read full office action

Prosecution Timeline

Jul 19, 2023
Application Filed
Apr 02, 2026
Non-Final Rejection — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12605707
Method for Conveying at Least One First Medium Within a Channel System of a Microfluidic Device
4y 7m to grant Granted Apr 21, 2026
Patent 12596125
NANO-RHEOLOGICAL BIOMARKERS FOR EARLY AND IMPROVED FOLLOW-UP OF PATHOLOGIES ASSOCIATED TO RBC DEFORMABILITY ALTERATION
4y 3m to grant Granted Apr 07, 2026
Patent 12595474
DNA DATA STORAGE ON TWO-DIMENSIONAL SUPPORT MATERIAL
3y 6m to grant Granted Apr 07, 2026
Patent 12566141
PERACETIC ACID FORMULATION CONCENTRATION DETERMINATION METHOD
4y 0m to grant Granted Mar 03, 2026
Patent 12560545
Colorimetric Measurement of Fludioxonil
3y 3m to grant Granted Feb 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
58%
Grant Probability
89%
With Interview (+31.1%)
3y 4m (~6m remaining)
Median Time to Grant
Low
PTA Risk
Based on 714 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month